Literature DB >> 116225

Proton-dependent inhibition of yeast and brain hexokinases by aluminum in ATP preparations.

F C Womack, S P Colowick.   

Abstract

The aluminum present as a contaminant in ATP preparations can cause strong inhibition of yeast hexokinase P-II activity at pH 7.0 or below but has little or no inhibitory effect at a pH of 7.5 or greater. The inhibition is reversed by citrate, 3-phosphoglycerate, malate, phosphate, and catecholamines, all of which have previously been described as activators of hexokinase at low pH. We suggest that these agents activate the enzyme only by virtue of their ability to coordinate with aluminum present in the assay system. The presence of aluminum is also responsible for the "negative cooperativity" observed at low pH with respect to Mg . ATP concentration--i.e., the inhibition by aluminum is uncompetitive at low Mg . ATP concentrations but becomes competitive at high Mg . ATP concentrations. The inhibition is thought to be due to formation of a complex of Al . ATP with the enzyme, with a dissociation constant (Ki) of 0.1 microM. Yeast hexokinase P-I is somewhat less sensitive to A1 than is hexokinase P-II, and yeast glucokinase is not detectably affected. The hexokinase in rat brain (type I) shows a pH-dependent inhibition by Al similar to that observed with the yeast hexokinases, whereas the rat muscle (type II) enzyme is less sensitive, suggesting a possible relationship to aluminum encephalopathy in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116225      PMCID: PMC413083          DOI: 10.1073/pnas.76.10.5080

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Regulatory properties of yeast hexokinase PII. Metal specificity, nucleotide specificity, and buffer effects.

Authors:  B A Peters; K E Neet
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

2.  Effects of fructose 6-phosphate and adenylates on the activities of rabbit liver fructose bisphosphatase and phosphofructokinase.

Authors:  R W McClard; D E Atkinson
Journal:  Arch Biochem Biophys       Date:  1979-04-15       Impact factor: 4.013

3.  Purine nucleoside diphosphate regulation of yeast hexokinases.

Authors:  F C Womack; S P Colowick
Journal:  Arch Biochem Biophys       Date:  1978-12       Impact factor: 4.013

Review 4.  Dialysis encephalopathy syndrome.

Authors:  A C Alfrey
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

5.  Monomer-dimer equilibria of yeast hexokinase during reacting enzyme sedimentation.

Authors:  J P Shill; B A Peters; K E Neet
Journal:  Biochemistry       Date:  1974-09-10       Impact factor: 3.162

6.  Purification and serological comparison of the yeast hexokinases P-I and P-II.

Authors:  F C Womack; M K Welch; J Nielsen; S P Colowick
Journal:  Arch Biochem Biophys       Date:  1973-10       Impact factor: 4.013

7.  Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration.

Authors:  D R Crapper; S S Krishnan; A J Dalton
Journal:  Science       Date:  1973-05-04       Impact factor: 47.728

8.  Yeast hexokinase mutants.

Authors:  J M Gancedo; D Clifton; D G Fraenkel
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

9.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle.

Authors:  L C Cantley; L Josephson; R Warner; M Yanagisawa; C Lechene; G Guidotti
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

10.  Rabbit muscle phosphofructokinase. Modification of molecular and regulatory kinetic properties with the affinity label 5'-p-(fluorosulfonyl)benzoyl adenosine.

Authors:  D W Pettigrew; C Frieden
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

View more
  16 in total

1.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Inhibition of H+-transporting ATPase by formation of a tight nucleoside diphosphate-fluoroaluminate complex at the catalytic site.

Authors:  J Lunardi; A Dupuis; J Garin; J P Issartel; L Michel; M Chabre; P V Vignais
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  P2-purinergic control of liver glycogenolysis.

Authors:  S Keppens; H De Wulf
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

4.  Kinetics of the cooperative binding of glucose to dimeric yeast hexokinase P-I.

Authors:  J G Hoggett; G L Kellett
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  Effects of aluminium on electrical and mechanical properties of frog atrial muscle.

Authors:  H Meiri; Y Shimoni
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

6.  Studies of aluminum in rat brain.

Authors:  J J Lipman; A B Brill; P Som; K W Jones; S Colowick; M Cholewa
Journal:  Biol Trace Elem Res       Date:  1987-08       Impact factor: 3.738

7.  Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum.

Authors:  M G Sturr; R E Marquis
Journal:  Arch Microbiol       Date:  1990       Impact factor: 2.552

8.  (13)C heteronuclear NMR studies of the interaction of cultured neurons and astrocytes and aluminum blockade of the preferential release of citrate from astrocytes.

Authors:  Shunsuke Meshitsuka; David A Aremu
Journal:  J Biol Inorg Chem       Date:  2007-11-15       Impact factor: 3.358

9.  Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride.

Authors:  P C Sternweis; A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Aluminum: a pH-dependent inhibitor of NADP-isocitrate dehydrogenase from porcine heart.

Authors:  M Yoshino; K Murakami
Journal:  Biometals       Date:  1992       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.